Management of B-cell non-Hodgkin lymphoma in Asia: resource-stratified guidelines

被引：25

作者：

Tan, Daryl ^{[1
,2
]}

Tan, Soo Yong ^{[3
,4
,5
]}

Lim, Soon Thye ^{[4
,6
]}

Kim, Seok Jin ^{[7
]}

Kim, Won-Seog ^{[7
]}

Advani, Ranjana ^{[8
]}

Kwong, Yok-Lam ^{[9
]}

机构：

[1] Raffl Hosp, Raffl Canc Ctr, Singapore 88770, Singapore

[2] Singapore Gen Hosp, Dept Haematol, Singapore, Singapore

[3] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore

[4] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore

[5] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore

[6] Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore

[7] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea

[8] Stanford Univ, Ctr Comprehens Canc, Stanford, CA 94305 USA

[9] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China

来源：

LANCET ONCOLOGY | 2013年 / 14卷 / 12期

关键词：

CHOP PLUS RITUXIMAB; RANDOMIZED CONTROLLED-TRIAL; DIFFUSE LARGE-CELL; TERM-FOLLOW-UP; BONE-MARROW-TRANSPLANTATION; GRADE FOLLICULAR LYMPHOMA; PROGRESSION-FREE SURVIVAL; CHRONIC HEPATITIS-B; HIGH-DOSE THERAPY; PHASE-II;

D O I：

10.1016/S1470-2045(13)70450-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Treatment of B-cell non-Hodgkin lymphomas has undergone substantial developments in the past 10 years. The introduction of rituximab has greatly improved survival outcomes in patients. Clinical practice guidelines based on current evidence have been developed to provide recommendations for standard treatment approaches. However, guidelines do not take into account resource limitations in resource-poor countries. The huge disparities in economy, health-care infrastructure, and access to novel drugs between Asian countries can hinder the delivery of optimum care to patients with lymphoma in Asia. We outline guidelines appropriate to different levels of health-care resources and expertise, aiming to provide advice on diagnosis and treatment, unify interpretation of results, and allow the design of future studies in Asia. In this resource-adapted consensus, we summarise recommendations for diagnosis, staging, risk stratification, and treatment of common B-cell non-Hodgkin lymphomas in Asia.

引用

页码：E548 / E561

页数：14

共 130 条

[21] An update of the epidemiology of non-Hodgkin's lymphoma [J].

Chiu, BCH ;

Weisenburger, DD .

CLINICAL LYMPHOMA, 2003, 4 (03) :161-168

[22] A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy [J].

Choi, William W. L. ;

Weisenburger, Dennis D. ;

Greiner, Timothy C. ;

Piris, Miguel A. ;

Banham, Alison H. ;

Delabie, Jan ;

Braziel, Rita M. ;

Geng, Huimin ;

Iqbal, Javeed ;

Lenz, Georg ;

Vose, Julie M. ;

Hans, Christine P. ;

Fu, Kai ;

Smith, Lynette M. ;

Li, Min ;

Liu, Zhongfeng ;

Gascoyne, Randy D. ;

Rosenwald, Andreas ;

Ott, German ;

Rimsza, Lisa M. ;

Campo, Elias ;

Jaffe, Elaine S. ;

Jaye, David L. ;

Staudt, Louis M. ;

Chan, Wing C. .

CLINICAL CANCER RESEARCH, 2009, 15 (17) :5494-5502

[23] Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin's lymphoma [J].

Clark, FL ;

Drummond, MW ;

Chambers, S ;

Chapman, BA ;

Patton, WN .

ANNALS OF ONCOLOGY, 1998, 9 (04) :385-387

[24] Lymphoid Malignancies in US Asians: Incidence Rate Differences by Birthplace and Acculturation [J].

Clarke, Christina A. ;

Glaser, Sally L. ;

Gomez, Scarlett L. ;

Wang, Sophia S. ;

Keegan, Theresa H. ;

Yang, Juan ;

Chang, Ellen T. .

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (06) :1064-1077

[25] CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. [J].

Coiffier, B ;

Lepage, E ;

Brière, J ;

Herbrecht, R ;

Tilly, H ;

Bouabdallah, R ;

Morel, P ;

Van den Neste, E ;

Salles, G ;

Gaulard, P ;

Reyes, F ;

Gisselbrecht, C .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) :235-242

[26]

Crump M, 2012, 54 AM SOC HEM ANN M

[27] Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles [J].

Cunningham, David ;

Hawkes, Eliza A. ;

Jack, Andrew ;

Qian, Wendi ;

Smith, Paul ;

Mouncey, Paul ;

Pocock, Christopher ;

Ardeshna, Kirit M. ;

Radford, John A. ;

McMillan, Andrew ;

Davies, John ;

Turner, Deborah ;

Kruger, Anton ;

Johnson, Peter ;

Gambell, Joanna ;

Linch, David .

LANCET, 2013, 381 (9880) :1817-1826

[28] Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells [J].

Dave, SS ;

Wright, G ;

Tan, B ;

Rosenwald, A ;

Gascoyne, RD ;

Chan, WC ;

Fisher, RI ;

Braziel, RM ;

Rimsza, LM ;

Grogan, TM ;

Miller, TP ;

LeBlanc, M ;

Greiner, TC ;

Weisenburger, DD ;

Lynch, JC ;

Vose, J ;

Armitage, JO ;

Smeland, EB ;

Kvaloy, S ;

Holte, H ;

Delabie, J ;

Connors, JM ;

Lansdorp, PM ;

Ouyang, Q ;

Lister, TA ;

Davies, AJ ;

Norton, AJ ;

Muller-Hermelink, HK ;

Ott, G ;

Campo, E ;

Montserrat, E ;

Wilson, WH ;

Jaffe, ES ;

Simon, R ;

Yang, LM ;

Powell, J ;

Zhao, H ;

Goldschmidt, N ;

Chiorazzi, M ;

Staudt, LM .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (21) :2159-2169

[29] Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial [J].

Delarue, Richard ;

Tilly, Herve ;

Mounier, Nicolas ;

Petrella, Tony ;

Salles, Gilles ;

Thieblemont, Catherine ;

Bologna, Serge ;

Ghesquieres, Herve ;

Hacini, Maya ;

Fruchart, Christophe ;

Ysebaert, Loic ;

Ferme, Christophe ;

Casasnovas, Olivier ;

Van Hoof, Achiel ;

Thyss, Antoine ;

Delmer, Alain ;

Fitoussi, Olivier ;

Molina, Thierry Jo ;

Haioun, Corinne ;

Bosly, Andre .

LANCET ONCOLOGY, 2013, 14 (06) :525-533

[30] Results of a national consensus workshop:: therapeutic algorithm in patients with follicular lymphoma -: role of radioimmunotherapy [J].

Dreyling, M. ;

Truemper, L. ;

von Schilling, C. ;

Rummel, M. ;

Holtkamp, U. ;

Waldmann, A. ;

Wehmeyer, J. ;

Freund, M. .

ANNALS OF HEMATOLOGY, 2007, 86 (02) :81-87

← 1 2 3 4 5 6 7 8 9 10 →